NCT05632913View on ClinicalTrials.gov

Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2027

Conditions
Recurrent Lung CancerLung Cancer
Interventions
DEVICE

Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

An intratumoral insertion of radioactive sources \[Ra-224 containing stainless-steel 316LVM tubes- (Alpha DaRT seeds)\]. The seeds release by recoil into the tumor short-lived alpha-emitting atoms

Trial Locations (1)

9777605

RECRUITING

Hadassah University Hospital, Jerusalem

Sponsors
All Listed Sponsors
lead

Alpha Tau Medical LTD.

INDUSTRY